| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.EURURO.2012.04.024 |
| P8608 | Fatcat ID | release_jmcz6dcuojg3vdrn7kzfmpyonq |
| P932 | PMC publication ID | 3389180 |
| P698 | PubMed publication ID | 22541389 |
| P5875 | ResearchGate publication ID | 224865241 |
| P50 | author | Juni Palmgren | Q4971780 |
| Hans-Olov Adami | Q5542230 | ||
| Andrew Vickers | Q20055453 | ||
| Lars Holmberg | Q30582855 | ||
| Gunnar Steineck | Q39509247 | ||
| Hans Garmo | Q42886262 | ||
| Jan-Erik Johansson | Q88446186 | ||
| Anna Bill-Axelson | Q114430958 | ||
| P2093 | author name string | Caroline Bennette | |
| P2860 | cites work | Cancer statistics, 2010 | Q27860525 |
| Time trends in clinical risk stratification for prostate cancer: implications for outcomes (data from CaPSURE). | Q30883910 | ||
| Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer | Q33318333 | ||
| Comparative effectiveness of prostate cancer treatments: evaluating statistical adjustments for confounding in observational data. | Q33718192 | ||
| Active surveillance for prostate cancer: patient selection and management. | Q34111584 | ||
| Active surveillance compared with initial treatment for men with low-risk prostate cancer: a decision analysis | Q34659767 | ||
| Outcomes of active surveillance for men with intermediate-risk prostate cancer | Q34679207 | ||
| The surgical learning curve for laparoscopic radical prostatectomy: a retrospective cohort study | Q34973835 | ||
| Expectant management of prostate cancer with curative intent: an update of the Johns Hopkins experience | Q35322578 | ||
| Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancer group-4 randomized trial | Q36841565 | ||
| Insignificant prostate cancer and active surveillance: from definition to clinical implications | Q37414935 | ||
| Active surveillance for the management of prostate cancer in a contemporary cohort | Q39843996 | ||
| An evidence based approach to individualising treatment | Q41849533 | ||
| Role of prostate specific antigen and immediate confirmatory biopsy in predicting progression during active surveillance for low risk prostate cancer | Q42215015 | ||
| Predicting biochemical recurrence-free survival for patients with positive pelvic lymph nodes at radical prostatectomy | Q42501562 | ||
| A decision aid to assist in adjuvant therapy choices for breast cancer | Q42681645 | ||
| Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer | Q44199886 | ||
| The surgical learning curve for prostate cancer control after radical prostatectomy. | Q51980130 | ||
| Prostate cancer and the Will Rogers phenomenon. | Q52991881 | ||
| A Study of Diffusion-Weighted Magnetic Resonance Imaging in Men with Untreated Localised Prostate Cancer on Active Surveillance | Q63966739 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | prostate cancer | Q181257 |
| P304 | page(s) | 204-209 | |
| P577 | publication date | 2012-04-19 | |
| P1433 | published in | European Urology | Q15763991 |
| P1476 | title | Individualized estimation of the benefit of radical prostatectomy from the Scandinavian Prostate Cancer Group randomized trial | |
| P478 | volume | 62 |
| Q36414849 | A hospital-based study of initial observation for low-risk prostate cancer and its predictors in the United States |
| Q26800823 | A systematic review of randomised controlled trials of radiotherapy for localised prostate cancer |
| Q38194533 | Active surveillance for clinically localized prostate cancer--a systematic review |
| Q44245825 | Active surveillance for localized prostate cancer: an analysis of patient contacts and utilization of healthcare resources. |
| Q48275350 | Active surveillance for localized prostate cancer: update of a prospective single-center cohort |
| Q37003387 | Age remains the major predictor of curative treatment non-receipt for localised prostate cancer: a population-based study |
| Q55234387 | Are Elderly Patients With Clinically Localized Prostate Cancer Overtreated? Exploring Heterogeneity in Survival Effects. |
| Q38151298 | Can we improve the definition of high-risk, hormone naïve, non-metastatic prostate cancer? |
| Q43595827 | Changes in preoperative characteristics in patients undergoing radical prostatectomy--a 16-year nationwide analysis. |
| Q37605565 | Comparative effectiveness of radical prostatectomy and radiotherapy in prostate cancer: observational study of mortality outcomes. |
| Q90392883 | Decrease in Intercourse Satisfaction in Men Who Recover Erections After Radical Prostatectomy |
| Q35188264 | Disease-specific outcomes of radical prostatectomies in Northern Norway; a case for the impact of perineural infiltration and postoperative PSA-doubling time |
| Q34992168 | ESTIMATING PERSON-CENTERED TREATMENT (PeT) EFFECTS USING INSTRUMENTAL VARIABLES: AN APPLICATION TO EVALUATING PROSTATE CANCER TREATMENTS. |
| Q40616371 | Effects of modified inclusion criteria and negative reporting about PSA screening on the number of potentially recruitable patients for the PREFERE study |
| Q35089983 | Empirical estimates of prostate cancer overdiagnosis by age and prostate-specific antigen |
| Q40120521 | Employment and sick leave in patients with prostate cancer before, during and after radiotherapy |
| Q34458237 | Expected population impacts of discontinued prostate-specific antigen screening |
| Q38742669 | Exploring the Optimal Erectile Function Domain Score Cutoff That Defines Sexual Satisfaction After Radical Prostatectomy. |
| Q44657084 | Fifteen-year mortality after radical prostatectomy: which factors are available for patient counselling? |
| Q38367054 | Four flawed arguments against prostate-specific antigen screening (and 1 good one). |
| Q35443808 | High miR-449b expression in prostate cancer is associated with biochemical recurrence after radical prostatectomy |
| Q28611347 | Increasing value and reducing waste: addressing inaccessible research |
| Q35147324 | Longitudinal trends in prostate cancer incidence, mortality, and survival of patients from two Shanghai city districts: a retrospective population-based cohort study, 2000-2009. |
| Q38392947 | Probability of extraprostatic disease according to the percentage of positive biopsy cores in clinically localized prostate cancer |
| Q89125005 | Prognosis, Effect Modification, and Mediation |
| Q40216437 | Prostate cancer antigen-3 (PCA3) and PCA3-based nomograms in the diagnosis of prostate cancer: an external validation of Hansen's nomogram on a Norwegian cohort |
| Q27025607 | Prostate cancer treatment: the times they are a' changin' |
| Q87855805 | Prostate cancer: surgery versus observation for localized prostate cancer |
| Q48282722 | Prostatectomy-based validation of combined urine and plasma test for predicting high grade prostate cancer |
| Q40800098 | Questioning the 10-year Life Expectancy Rule for High-grade Prostate Cancer: Comparative Effectiveness of Aggressive vs Nonaggressive Treatment of High-grade Disease in Older Men With Differing Comorbid Disease Burdens |
| Q38517738 | Radical Prostatectomy for Locally Advanced Prostate Cancer: Current Status |
| Q57131976 | Radical prostatectomy in high-risk prostate cancer |
| Q41847374 | Radical prostatectomy is the most cost-effective primary treatment modality for men diagnosed with high-risk prostate cancer |
| Q91336389 | Recognizing and minimizing bias: Helping patients make their best choice for prostate cancer management through multidisciplinary clinics |
| Q42567335 | Results of radical prostatectomy in newly diagnosed prostate cancer: long-term survival rates in locally advanced and high-risk cancers |
| Q44847025 | Survival after radical prostatectomy for clinically localised prostate cancer: a population-based study. |
| Q47966928 | Survival outcomes in elderly men undergoing radical prostatectomy in Australia. |
| Q34512629 | The Memorial Sloan Kettering Cancer Center Recommendations for Prostate Cancer Screening |
| Q35832153 | The biology and treatment of oligometastatic cancer |
| Q35030034 | The science of clinical practice: disease diagnosis or patient prognosis? Evidence about "what is likely to happen" should shape clinical practice. |
| Q37201922 | Timing of curative treatment for prostate cancer: a systematic review |
| Q92894326 | Translating clinical trial results into personalized recommendations by considering multiple outcomes and subjective views |
| Q86754165 | Treatment and 5-year survival in patients with nonmetastatic prostate cancer: the Norwegian experience |
| Q93182682 | Variation in surgical treatment patterns for patients with prostate cancer in the United States: Do patients in academic hospitals fare better? |
| Q87423395 | [Importance of radical prostatectomy for patients older than 70 years] |
| Q87258473 | [PREFERE--open questions] |
Search more.